Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis
- PMID: 25001890
- DOI: 10.1007/s00586-014-3416-6
Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis
Abstract
Purpose: The debate on the effects and outcome of olfactory ensheathing cell (OEC) transplantation for the treatment of spinal cord injury (SCI) has remained unresolved for nearly 20 years. This study aimed to evaluate the safety and efficacy of OEC transplantation in chronic SCI patients.
Method: Electronic databases, including PubMed, the Cochrane Library, EMBASE, and MEDLINE, were searched to identify clinical therapeutic trials studying the use of OEC transplantation for SCI in humans. Each trial was analyzed in accordance with the criteria of the Cochrane Handbook 5.1.0 and MOOSE. Data were analyzed with Review Manager 5.2 and Meta-Analyst Beta 3.13 software.
Results: Eleven articles concerning 10 studies of 1,193 patients with chronic SCI treated with OEC transplantation were selected for review. All the articles had low methodological quality. Studies reported their outcomes using the American Spinal Injury Association (ASIA) Impairment Scale; the AISA motor, light touch, pinprick score; the Functional Independence Measure and (or) other measure methods. According to the available relevant data, the incidences of total adverse events and mortality were 7.68% (n = 742) and 0.35% (n = 566), respectively. The most frequently reported adverse events were fever, mild anemia, and syringomyelia; however, the statistical adverse events occurring in different studies were cerebrospinal fluid leakage (7.00%, n = 586, 2 trials), sensory deterioration (0.70%, n = 573, 2 trials), and both motor and sensory deterioration (0.68%, n = 586, 2 trials).
Conclusions: Given the results from our study, we conclude that OEC transplantation appears to be safe, although the evidence for efficacy is modest and requires the support of prospective, randomized trials in larger cohorts of patients. Further randomized controlled trials utilizing strict therapy programs and implanted cell selections are needed to confirm these findings.
Similar articles
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Management of faecal incontinence and constipation in adults with central neurological diseases.Cochrane Database Syst Rev. 2013 Dec 18;(12):CD002115. doi: 10.1002/14651858.CD002115.pub4. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2014 Jan 13;(1):CD002115. doi: 10.1002/14651858.CD002115.pub5. PMID: 24347087 Updated.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
Cited by
-
Heterogeneity and Potency of Peripheral Glial Cells in Embryonic Development and Adults.Front Mol Neurosci. 2022 Mar 25;15:737949. doi: 10.3389/fnmol.2022.737949. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35401107 Free PMC article. Review.
-
Transplantation of encapsulated autologous olfactory ensheathing cell populations expressing chondroitinase for spinal cord injury: A safety and feasibility study in companion dogs.J Tissue Eng Regen Med. 2022 Sep;16(9):788-798. doi: 10.1002/term.3328. Epub 2022 Jun 10. J Tissue Eng Regen Med. 2022. PMID: 35686704 Free PMC article.
-
Low-dose curcumin stimulates proliferation, migration and phagocytic activity of olfactory ensheathing cells.PLoS One. 2014 Oct 31;9(10):e111787. doi: 10.1371/journal.pone.0111787. eCollection 2014. PLoS One. 2014. PMID: 25360677 Free PMC article.
-
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.Int J Mol Sci. 2020 Oct 6;21(19):7380. doi: 10.3390/ijms21197380. Int J Mol Sci. 2020. PMID: 33036265 Free PMC article. Review.
-
Comparing the Efficacy and Safety of Cell Transplantation for Spinal Cord Injury: A Systematic Review and Bayesian Network Meta-Analysis.Front Cell Neurosci. 2022 Apr 4;16:860131. doi: 10.3389/fncel.2022.860131. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35444516 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical